484 related articles for article (PubMed ID: 35789865)
1. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.
Ahmed Juvale II; Abdul Hamid AA; Abd Halim KB; Che Has AT
Heliyon; 2022 Jun; 8(6):e09777. PubMed ID: 35789865
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporters in reproduction: a new frontier.
Bloise E; Ortiga-Carvalho TM; Reis FM; Lye SJ; Gibb W; Matthews SG
Hum Reprod Update; 2016; 22(2):164-81. PubMed ID: 26545808
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
6. A primer on the mechanics of P-glycoprotein the multidrug transporter.
Hennessy M; Spiers JP
Pharmacol Res; 2007 Jan; 55(1):1-15. PubMed ID: 17095241
[TBL] [Abstract][Full Text] [Related]
7. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
8. New insight into p-glycoprotein as a drug target.
Breier A; Gibalova L; Seres M; Barancik M; Sulova Z
Anticancer Agents Med Chem; 2013 Jan; 13(1):159-70. PubMed ID: 22931413
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the multidrug transporter.
Germann UA
Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
11. Importance of P-glycoprotein at blood-tissue barriers.
Fromm MF
Trends Pharmacol Sci; 2004 Aug; 25(8):423-9. PubMed ID: 15276711
[TBL] [Abstract][Full Text] [Related]
12. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
13. ABC Transporter-Mediated Multidrug-Resistant Cancer.
Amawi H; Sim HM; Tiwari AK; Ambudkar SV; Shukla S
Adv Exp Med Biol; 2019; 1141():549-580. PubMed ID: 31571174
[TBL] [Abstract][Full Text] [Related]
14. Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein.
Xia D; Zhou F; Esser L
Cancer Drug Resist; 2019; 2(3):471-489. PubMed ID: 35582581
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance.
Tiirikainen MI; Krusius T
Ann Med; 1991; 23(5):509-20. PubMed ID: 1684512
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon-Cardo C; O'Brien JP; Casals D; Rittman-Grauer L; Biedler JL; Melamed MR; Bertino JR
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):695-8. PubMed ID: 2563168
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
Fromm MF
Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
[TBL] [Abstract][Full Text] [Related]
18. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
19. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms.
Blackmore CG; McNaughton PA; van Veen HW
Mol Membr Biol; 2001; 18(1):97-103. PubMed ID: 11396617
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
